Biogen has an ambitious goal of serving 1,000,000 patients with Alzheimer's Disease by 2020. To achieve this, Biogen is rethinking all aspects of their biologics manufacturing, from advanced controls and predictive models to improved testing and analytical instruments. To deliver on this critical mission, the Biogen Execution Systems are being developed to provide fully integrated, data-driven, electronic paperless manufacturing, warehouse management, and quality controls. This presentation will describe the business drivers behind Biogen's Next Generation Manufacturing, the novel approaches to achieve the scale and throughput required and the systems required to deliver the vision. The presentation will focus on the critical role that data systems, and specifically OSIsoft PI System, play and the key functions enabled by the data systems.
Tim has over 20 years of process automation, operations management, and data analytics experience in the Biologics industry with such leading companies as Biogen, Sanofi, Genzyme, and Emerson Process Management. Currently, Tim is the head of the Global Data Analytics team for Biogen’s Pharmaceutical Operations & Technology IT within the Execution Systems department. The Execution System department develops standards and solutions for shop floor data, process control and manufacturing execution systems. These solutions are utilized across Biogen’s global manufacturing network. Prior to his work at Biogen, Tim has held leadership positions at Sanofi, Genzyme, and New England Controls, the local Emerson Process Management representative. Tim has a degree in Chemical Engineering from Massachusetts Institute of Technology.